Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1AGALSIDASE BETA1件: Agalsidase beta1件: D03228 (Name: Agalsidase beta)1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
2Agalsidase beta (GZ419828)1件: Agalsidase beta1件: D03228 (Name: Agalsidase beta)1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
3Agalsidase beta (recombinant form)1件: Agalsidase beta1件: D03228 (Name: Agalsidase beta)1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
4Agalsidase beta from Biosidus 1 mg/kg1件: Agalsidase beta1件: D03228 (Name: Agalsidase beta)1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
5Fabrazyme (agalsidase beta)1件: Agalsidase beta1件: D03228 (Name: Agalsidase beta)1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19
6Fabrazyme (agalsidase beta) 1 mg/kg1件: Agalsidase beta1件: D03228 (Name: Agalsidase beta)1件: GLA 💬6件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬1件: 19